Skip to main content
. Author manuscript; available in PMC: 2009 Jul 22.
Published in final edited form as: Am J Cardiol. 2009 Mar 13;103(9):1269–1274. doi: 10.1016/j.amjcard.2009.01.026

Table 2.

Multivariable model with myeloperoxidase (MPO) expressed in quartiles, including subjects with history of myocardial infarction (MI)

HR (95% CI) p Value HR* (95% CI) p Value
MPO quartiles (pmol/L)
 <170 1.0 (reference) 1.0 (reference)
 170–261 1.2 (0.94–1.52) 0.138 1.18 (0.92–1.50) 0.190
 262–432 0.94 (0.73–1.21) 0.623 0.92 (0.71–1.18) 0.505
 >432 1.34 (1.06–1.72) 0.013 1.22 (0.96–1.57) 0.108
MI 4.91 (4.08–5.91) <0.01 4.73 (3.92–5.71) <0.01
Age (yrs) 1.08 (1.07–1.10) <0.01 1.08 (1.06–1.10) <0.01
Men 1.16 (0.98–1.39) 0.09 1.21 (1.01–1.44) 0.034
Systolic blood pressure (mm Hg) 1.26 (1.16–1.36) <0.01 1.21 (1.12–1.31) <0.01
Smoker (current) 1.50 (1.15–1.97) <0.01 1.44 (1.10–1.90) <0.01
LDL cholesterol (mg/dl) 0.93 (0.85–1.01) 0.13 0.93 (0.85–1.02) 0.103
Diabetes mellitus 1.92 (1.56–2.36) <0.01 1.86 (1.50–2.30) <0.01
Subclinical cardiovascular diseases 1.93 (1.53–2.43) <0.01 1.87 (1.48–2.36) <0.01
C-Reactive protein 1.13 (1.06–1.20) <0.01
Cystatin C 1.22 (1.15–1.29) <0.01
*

When CRP and cystatin C were added to the multivariate model.

Per standard deviation increments (systolic blood presure = 21 mmHg, LDL cholesterol = 33 mg/dL, C-reactive protein = 9.4 mg/L, cystatin C = 0.28 mg/L).